Novel Strategies for Reducing Burn Scar Itch
Recruiting
Phase 3
Interventional Study
Burn Scar
Itch Scarring
Wound
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 44 (estimated)
- Sponsor
- The University of Texas Medical Branch, Galveston · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants must meet all the inclusion criteria in order to be eligible to participate in the study.
* Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
* Adults: ≥18 to \<80 years of age.
* …
Contacts